相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存:
394
- 英文名:
Recombinant Human Epidermal Growth Factor Receptor/Receptor Tyrosine Protein Kinase ErbB1
- 保质期:
长期
- 供应商:
北京百奥莱博科技有限公司
- 保存条件:
冻干蛋白置于-20℃以下可长期保存,室温
- 规格:
10μg|50μg|500μg|1mg
特别提示:包括重组人表皮生长因子受体(EGFR)(HER1 mutant)在内,本公司的所有产品仅可用于科研实验,严禁用于临床医疗及其他非科研用途!
产品名称:重组人表皮生长因子受体(EGFR)(HER1 mutant)
英文名称:Recombinant Human Epidermal Growth Factor Receptor/Receptor Tyrosine Protein Kinase ErbB1
产品货号:JN1439
产品规格:10μg|50μg|500μg|1mg
本品由我们的哺乳动物细胞表达系统制备而成,目的基因编码的Leu25-Val30Gly&Asn298-Ser645在C端带有Fc标签。
EGFR/HER1 mutant质量控制:>95%(还原性SDS-PAGE)
EGFR/HER1 mutant制剂:冻干品
EGFR/HER1 mutant保存:
冻干蛋白置于-20℃以下可长期保存,室温条件下可稳定保存3周。
复溶蛋白溶液可在4~7℃保存2~7天,可分装后置于-20℃保存三个月。
EGFR/HER1 mutant复溶:
打开试剂管前请先离心。
复溶浓度推荐大于100 μg/ml。
冻干蛋白请溶于ddH2O。
复溶后,请根据用量分装冻存,避免反复冻融。
关于EGFR/HER1 mutant:
The EGFR subfamily of receptor tyrosine kinases is composed of EGFR, ErbB2, ErbB3 and ErbB4. The EGFR shares 43% - 44% aa sequence identity with the ECD of human EGFR subfamily. All these family members are type I transmembrane glycoproteins with an extracellular ligand binding domain. The extracellular ligand binding domain is containing two cysteine-rich domains separated by a spacer region and a cytoplasmic domain containing a membrane-proximal tyrosine kinase domain. Ligand binding could induce EGFR homodimerization and heterodimerization with ErbB2, resulting in cell signaling, heterodimerization tyrosine phosphorylation and kinase activation. It can bind EGF, amphiregulin, TGF-alpha, betacellulin, epiregulin, HB-EGF, epigen, and so on. Its signaling regulates multiple biological functions including cell proliferation, differentiation, motility, and apoptosis. EGFR can also be recruited to form heterodimers with the ligand-activated ErbB3 or ErbB4. EGFR is overexpressed in different tumors. Several anti-cancer drugs use EGFR as target.
除了重组人表皮生长因子受体(EGFR)(HER1 mutant),,我公司还供应以下相关产品:
名称:重组人白介素IL-10(白细胞介素10)
货号:JN0380
规格:10μg|50μg|500μg|1mg
本品由我们的哺乳动物表达系统制备,目的基因编码的Ser19-Asn178表达纯化而来。
IL-10质量控制:>95%(还原性SDS-PAGE)。
IL-10制剂:冻干品
IL-10保存:
冻干蛋白可在-20℃长期保存,室温也可稳定保存3周。
复溶蛋白溶液可在4~7℃保存2~7天。
复溶后建议分装冻存在-20℃,可保存3个月,应避免反复冻融。
IL-10复溶:
1、试剂开盖前请先离心。
2、复溶浓度应大于100 μg/ml.
3、冻干蛋白溶于ddH2O中
4、复溶后根据使用量分装保存,避免反复冻融。
关于IL-10:
Interleukin 10(IL10), also known as cytokine synthesis inhibitory factor (CSIF),is a secreted protein and belongs to the IL-10 family. IL-10 is secreted by many activated hematopoietic cell types as well as hepatic stellate cells, keratinocytes, and placental cytotrophoblasts . IL-10 is an anti-inflammatory TH2 cytokine that has a critical role in limiting the immune response to pathogens to prevent host damage. As IL-10 in produced in several T helper populations, it is proposed that it provides a feedback loop to limit the effector functions of macrophages and DCs on T cells. Once expressed, IL-10 signals through the IL-10 receptor (IL-10R) to activate STAT3. As IL-10 is a strong inhibitor of inflammation, it has become a viable biomarker for various diseases and conditions as well as a therapeutic molecule for certain conditions. In addition to elevated levels in parasitic infection, high expression levels of IL-10 are also found in retroviral infections inducing immunodeficiency. The immunosuppressive properties of IL-10 suggest a possible clinical use of IL-10 in suppressing rejections of grafts after organ transplantations
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验相同的抗表皮生长因子(EGFR-1、Her-1)受体药物 a. 古巴分子免疫学中心(CIM)的抗EGFR人源化单克隆抗体h-R3重组人源化单克隆抗体h-R3是采用基因 工程、单细胞克隆等现代生物技术研制的高科技生物药品,是一种专门治疗表皮生长因子受体(EGF-R)高表达肿瘤的人源化单克隆抗体,也就是人们常说的“生物导弹”。可用来治疗头颈部、胃、肺、乳腺、结肠、直肠、食道、宫颈等器官的上皮源性肿瘤。该产品的人源化程度高达98%,人源化的技术水平超出美国英克隆(ImClone
厦门大学的研究团队评估了 EGFR 作为三阴乳腺癌免疫治疗靶点的可能性,通过体内实验和体外实验的结果得出,EGFR CAR-T 细胞展示出对三阴乳腺癌细胞强大的杀伤效果和潜力,提出 EGFR CAR-T 可以进一步向临床方向进行探索,获益更多的患者。 三阴乳腺癌(TNBC)以其侵袭性强、复发快速和预后效果差而闻名。目前以嵌合抗原受体 T (CAR-T)细胞为首的免疫疗法,已经成为治疗 TNBC 的一种有效工具,而其中肿瘤特异性抗原的选择和 CAR 结构的设计成为 CAR-T 治疗的挑战。 中国
EGFR and Tumor Suppressor Function in Brain Cancer Development
interventions. Using cutting edge Cre/Lox technologies, we created compound conditional transgenic strains based on a Cre-induced expression of mutant EGFRvIII with the concomitant loss of the Cdkn2a and PTEN tumor suppressor genes. The introduction
技术资料暂无技术资料 索取技术资料









